Literature DB >> 9276736

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

C A Head1, C Brugnara, R Martinez-Ruiz, R M Kacmarek, K R Bridges, D Kuter, K D Bloch, W M Zapol.   

Abstract

The hallmark of sickle cell disease (SCD) is the polymerization of deoxygenated sickle hemoglobin (HbS). In SCD patients, one strategy to reduce red blood cell (RBC) sickling is to increase HbS oxygen affinity. Our objective was to determine if low concentrations of nitric oxide (NO) gas would augment the oxygen affinity of RBCs containing homozygous HbS (SS). Blood containing normal adult hemoglobin (AA) or SS RBCs was incubated in vitro in the presence of varying concentrations of NO up to 80 ppm, and oxygen dissociation curves (ODCs) were measured. In addition, blood was obtained from three AA and nine SS volunteers, before and after breathing 80 ppm NO in air for 45 min, and the ODCs were measured. Exposure of SS RBCs to 80 ppm NO in vitro for 5 min or longer decreased the partial pressure of oxygen at which hemoglobin is 50% saturated with oxygen (P50), an average of 15% (4.8+/-1.7 mmHg mean+/-SE; P < 0.001). The increase in SS RBC oxygen affinity correlated with the NO concentration. The P50 of AA RBCs was unchanged (P > 0.1) by 80 ppm NO. In SS volunteers breathing 80 ppm NO for 45 min, the P50 decreased (P < 0.001) by 4.6+/-2.0 mmHg. 60 min after NO breathing was discontinued, the RBC P50 remained decreased in five of seven volunteers in whom the ODC was measured. There was no RBC P50 change (P > 0.1) in AA volunteers breathing NO. Methemoglobin (Mhb) remained low in all subjects breathing NO (SS Mhb 1.4+/-0.5%), and there was no correlation (r = 0.02) between the reduction in P50 and the change in Mhb. Thus, low concentrations of NO augment the oxygen affinity of sickle erythrocytes in vitro and in vivo without significant Mhb production. These results suggest that low concentrations of NO gas may offer an attractive new therapeutic model for the treatment of SCD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276736      PMCID: PMC508295          DOI: 10.1172/JCI119631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The effect of methemoglobin formation in sickle cell disease.

Authors:  E BEUTLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

Authors:  J D Roberts; J R Fineman; F C Morin; P W Shaul; S Rimar; M D Schreiber; R A Polin; M S Zwass; M M Zayek; I Gross; M A Heymann; W M Zapol
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

3.  Effect of nitric oxide on the oxygen transport of human erythrocytes.

Authors:  K Kon; N Maeda; T Shiga
Journal:  J Toxicol Environ Health       Date:  1977-05

4.  Oxygen affinity as an index of hemoglobin S polymerization: a new micromethod.

Authors:  R E Benesch; R Edalji; S Kwong; R Benesch
Journal:  Anal Biochem       Date:  1978-08-15       Impact factor: 3.365

5.  Requirement for therapeutic inhibition of sickle haemoglobin gelation.

Authors:  H R Sunshine; J Hofrichter; W A Eaton
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

6.  Hb Okazaki [beta 93(F8) Cys----Arg], a new hemoglobin variant with increased oxygen affinity and instability.

Authors:  K Harano; T Harano; S Shibata; S Ueda; H Mori; M Seki
Journal:  FEBS Lett       Date:  1984-07-23       Impact factor: 4.124

7.  Cooperativity in the dissociation of nitric oxide from hemoglobin.

Authors:  E G Moore; Q H Gibson
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

8.  Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.

Authors:  W N Poillon; M D Robinson; B C Kim
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

9.  Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization.

Authors:  M C Garel; C Domenget; J Caburi-Martin; C Prehu; F Galacteros; Y Beuzard
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

10.  Covalent binding of glutathione to hemoglobin. II. Functional consequences and structural changes reflected in NMR spectra.

Authors:  C T Craescu; C Poyart; C Schaeffer; M C Garel; J Kister; Y Beuzard
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

View more
  25 in total

1.  Can we just say NO to sickle cell anemia?

Authors:  R L Nagel
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Physiological reactions of nitric oxide and hemoglobin: a radical rethink.

Authors:  S S Gross; P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

3.  The oxyhemoglobin reaction of nitric oxide.

Authors:  A J Gow; B P Luchsinger; J R Pawloski; D J Singel; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  Reaping of nitric oxide by sickle cell disease.

Authors:  Jack R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Sickle cell disease and aortic valve replacement: use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration.

Authors:  S W Sutton; E K Hunley; M A Duncan; R Rodriguez; T P Meyers
Journal:  Tex Heart Inst J       Date:  1999

6.  Inhaled nitric oxide delivery and monitoring.

Authors:  F J Montgomery; A D Berssenbrugge
Journal:  J Clin Monit Comput       Date:  1999-07       Impact factor: 2.502

7.  The pulmonary physician in critical care * Illustrative case 6: Acute chest syndrome of sickle cell anaemia.

Authors:  V Mak; S C Davies
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

8.  The role of beta93 Cys in the inhibition of Hb S fiber formation.

Authors:  Kelly M Knee; Catherine K Roden; Mark R Flory; Ishita Mukerji
Journal:  Biophys Chem       Date:  2007-02-16       Impact factor: 2.352

9.  Pharmacological management of sickle cell disease.

Authors:  Uche Anadu Ndefo; Angie Eaton Maxwell; Huong Nguyen; Tochukwu L Chiobi
Journal:  P T       Date:  2008-04

10.  Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability.

Authors:  Diana R Gutsaeva; Pedro Montero-Huerta; James B Parkerson; Shobha D Yerigenahally; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2014-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.